100% of all donations to ACGT
go directly to sponsoring research.
NEWS & UPDATES
Breakthrough of the year:
Cancer immunotherapy was selected as the "Breakthrough of the Year" in the December 2013 edition of Science, the flagship journal of the American Association for the Advancement of Science.
"Immunotherapy marks an entirely different way of treating cancer—by targeting the immune system, not the tumor itself," wrote Jennifer Couzin-Frankel, "This year, clinical trials have cemented its potential in patients."
Watch an Amazing Short Film of a Young Girl's Recovery
The innovative treatment using gene therapy – and the dedication of her medical team – is truly inspiring. This study was originally funded by ACGT. This moving film is by Ross Kauffman & DB Productions.
Grant Awarded to Dr. John Bell
Dr. John Bell, Ottawa Hospital Research Institute in Canada, is the recipient of the 2013 ACGT Investigator Award for Clinical Translation. A renowned cell and gene therapy researcher, and Professor of Medicine, Dr. Bell deploys a unique oncolytic virus to destroy brain cancer. Learn more about Dr. Bell...
Connecticut Magazine spotlights ACGT
Driving Force in Fight to Cure Cancer With Gene Therapy Is Stamford-Based
by Douglas P. Clement, Connecticut Magazine
“Our donors have allowed top scientific minds to explore this new and promising avenue of cancer treatment, and their philanthropy is directly linked to the lives saved so far,” Barbara Netter, ACGT president, said. “There’s a lot more hope than there ever was. It’s a very exciting time … the beginning of the Golden Age,” Netter described “real progress” being made through the results of research that have patients who faced dire diagnoses instead being in complete remission—not short-term but for years and counting.”
About 100 guests mingled with ACGT scientists who work on the frontlines of cancer research at the Harvard Club of New York City on October 15. After the reception the attendees heard a riveting and optimistic presentation about innovations in treatments that target only the cancer.
ACGT Scientific Advisory Council Chair Dr. Savio Woo introduced each of three ACGT Research Fellows who described how they are “Achieving Cancer Remission with Cell and Gene Therapies.” Dr. Carl June, University of Pennsylvania, Dr. Laurence Cooper, MD Anderson Cancer Center, and Dr. Michel Sadelain of Memorial Sloan-Kettering Cancer Center thanked ACGT for providing the initial funding that has enabled them to bring new therapies to patients. Download the ACGT press release (PDF)
SAVE THE DATE!
SAVE THE DATE! June 21, 2014 will be the 8th annual Swim Across America to benefit ACGT.
Learn from Dr. Carl June How Your Support of ACGT Made Life-Saving Leukemia Breakthrough Possible
View Our List of Fellows
Every day, thanks to your generosity, ACGT Grantees are making enormous progress in the treatments of Lymphoma, Leukemia, Multiple Myeloma, Neuroblastoma, Breast cancer, Ovarian cancer, Lung cancer, Brain cancer, Pancreatic cancer, and Prostate cancer. View a list of our Grantees.
ACGT is approved by the coalition of the Better Business Bureau and the National Charities Information Bureau. Read more...